NBHL to Participate in BIO Asia–Taiwan 2025

Dates: July 23 (Wed) – 27 (Sun), 2025
Location: Taipei, Taiwan（Venue: Taipei Nangang Exhibition Center Hall 1 (TaiNEX 1)
Format: On-site and online

We will showcase our proprietary GPCR-targeted antibody discovery platform, MoGRAA® Discovery Engine, together with our pre-clinical pipeline, to a global audience. Throughout the convention, we will actively seek partnership and investment opportunities with pharmaceutical companies and investors worldwide.

Individual meetings can be arranged via the event’s official partnering system.
Companies and investors interested in meeting with us are warmly encouraged to request an appointment.